ABOODY, D. y LEV, B. (1998): “The Value Relevance of Intangibles: The Case of Software Capitalizationâ€. Journal of Accounting Research, 36, pp. 161–191.
- ABOODY, D. y LEV, B. (2001): R&D Productivity in the Chemical Industry, New York (disponible en www.baruch-lev.com).
Paper not yet in RePEc: Add citation now
AHMED, K. y FALK, H. (2006): “The value relevance of managements research and development reporting choice: evidence from Australiaâ€. Journal of Accounting and Public Policy, 25 (3), pp. 231–264.
- AICPA (2011): Assets acquired to be used in research and development activities, American Institute of Certified Public Accountants, New York, USA.
Paper not yet in RePEc: Add citation now
AMIR, E. y LEV, B. (1996): “Value-relevance of nonfinancial information: the wireless communications industryâ€, Journal of Accounting and Economics, 22, pp. 3–30.
BARTH, M.E y CLINCH, G. (2009): “Scale Effects in Capital Markets-Based Accounting Researchâ€. Journal of Business Finance & Accounting, 36(3) & (4), pp. 253–288.
BARTH, M.E. y KALLAPUR, S. (1996): “The effects of Cross-Sectional Scale Differences on Regressions Results in Empirical Accounting Researchâ€. Contemporary Accounting Research, Vol. 13, pp. 527–567.
BROWN, S., LO, K. y LYS, T. (1999): “Use of R2 in accounting research: Measuring changes in value relevance over the last four decadesâ€. Journal of Accounting and Economics, 28, pp. 83–115.
CHOIW, W.; KWONS, S. y LOBOG, J. (2000): “Market valuation of Intangible Assetsâ€, Journal of Business Research, 49, pp. 35–45.
- CHOW, G.C. (1960): “Tests of equality between sets of coefficients in two linear regressionsâ€, Econometrica, N 28 (3), pp. 591–605.
Paper not yet in RePEc: Add citation now
CHUNG, K. y PRUIT, S. (1994): “A simple approximation of Tobin’s qâ€, Financial Management, Vol. 23, N 3, Autumn, pp. 70–74.
COLLINS, D.W., MAYDEW, E.L. y WEISS, I.S. (1997): “Changes in the value-relevance of earnings and book values over the past forty yearsâ€. Journal of Accounting and Economics, 24, pp. 39–67.
Contemporary Accounting Research, 21 (4), pp. 795–812. EASTON, P. y SOMMERS, G. (2003): “Scale and the Scale Effect in Market-based Accounting Researchâ€. Journal of Business, Finance & Accounting, Vol. 30, pp. 25–56.
CORE, J., GUAY, W. y VAN BUSKIRK, A. (2003): “Market valuations in the New Economy: An investigation of what has changedâ€. Journal of Accounting and Economics, 34, pp. 43– 67.
- DAMODARAN ONLINE: Updated data. Europe 2011. Disponible en: www.damodaran.com.
Paper not yet in RePEc: Add citation now
- DAMODARAN, A. (2006): Damodaran on valuation: security analysis for investment and corporate finance, 2 ed., John Wiley & Sons, New Jersey, USA.
Paper not yet in RePEc: Add citation now
- DANTOH, A., RADHAKRISHNAN, S. y RONEN, J. (2004): “The declining value-relevance of accounting information and non-information-based trading: An empirical analysisâ€.
Paper not yet in RePEc: Add citation now
FRANCIS, J. y SCHIPPER, K. (1999): “Have financial statements lost their relevance?â€.
- GORDON, M. (1962): The Investment, Financing and Valuation of the Corporation, Irwin&Co, Illinois, USA.
Paper not yet in RePEc: Add citation now
- GU, Z. (2005): “Scale Factor, R2, the Choice of Levels versus Returns Modelsâ€, Journal of Accounting, Auditing, & Finance, Vol. 20, Issue 1 (Winter), pp. 71–91.
Paper not yet in RePEc: Add citation now
- GUTIÉRREZ DE MESA VZQUEZ, E. y RUBIO MARTÃN, G. (2006): “La valoración de los activos intangibles en la empresa biofarmacéutica: Una reflexión crÃtica sobre la aplicación de las NIIFâ€. Partida Doble (178), pp. 18–30.
Paper not yet in RePEc: Add citation now
Journal of Accounting Research, 37 (2), pp. 319–352. GLEASON, K. y KLOCK, M. (2006): “Intangible capital in the pharmaceutical and chemical industryâ€, The Quarterly Review of Economics and Finance, 46, pp. 300–314.
- LARRN, J.M., y SOTOMAYOR, S. (2005): “Valoración y reconocimiento de activos intangiblesâ€. Revista Internacional Legis de Contabilidad y AuditorÃa, 21, enero-marzo, pp. 83–128.
Paper not yet in RePEc: Add citation now
- LEV, B. (1989): “One the Usefulness of Earning and Earning research: Lessons and directions from Two Decades of Empirical Researchâ€. Journal of accounting research, Vol. 27, pp.
Paper not yet in RePEc: Add citation now
- LEV, B. (2000): Knowledge and Shareholder Value: Working Paper, Stern School of Business, New York University, New York, USA.
Paper not yet in RePEc: Add citation now
- LEV, B. (2005): “Intangible Assets: Concepts and Measurementsâ€, Encyclopedia of Social Measurement, Vol. 2, pp. 299–305.
Paper not yet in RePEc: Add citation now
- LEV, B. y ZAROEIN, P. (1999): “The boundaries of financial reporting and how to extend themâ€. Journal of Accounting Research, 37 (2), pp. 353–385.
Paper not yet in RePEc: Add citation now
LIANG, C.J. y YAO, M.L. (2005): “The value-relevance of financial and nonfinancial information—Evidence from Taiwan’s information electronics industryâ€. Review of Quantitative Finance and Accounting, 24, pp. 135–175.
- MALKIEL, B.G. (2008): Un paseo aleatorio por Wall Street, 9 ed., Alianza Editorial, Madrid.
Paper not yet in RePEc: Add citation now
- NIIF 3, 13, NIC 36 y 38, International Accounting Standards Board (IASB). www.ifrs.org. OHLSON, J. (1995): “Earnings, book values and dividends in equity valuationâ€, Contemporary Accounting Research, Vol. 11, N 2, Spring, pp. 661–687.
Paper not yet in RePEc: Add citation now
OSWALD, D.R. (2008): “The determinants and value relevance of the choice of accounting for research and development expenditures in the United Kindomâ€, Journal of Business Finance & Accouting, 35 (1) & (2), January-March, pp. 1–24.
- OSWALD, D.R. y ZAROWIN, P. (2007): “Capitalization of R&D and the Inf ormativeness of Stock Pricesâ€. European Accounting Review, 16, pp. 703–726.
Paper not yet in RePEc: Add citation now
- PRICE WATER HOUSE COOPERS (2006): A review of the implementation of IRFS in the pharmaceuticals industry, Price Water House Coopers, Madrid.
Paper not yet in RePEc: Add citation now
- RUBIO, G. y LAMOTHE, P. (2010): “Valoración de las grandes corporaciones farmacéuticas, a través del análisis de sus principales intangibles, con el método de opciones realesâ€, Revista de EconomÃa Financiera, pp. 47–74.
Paper not yet in RePEc: Add citation now
- RUBIO, G., SOUSA, S. y MAROTO, J.A. (2012): “El valor razonable de la innovación en los estados financieros de las empresas farmacéuticas y biotecnológicas: la necesidad de elaborar un informe de capital intelectualâ€. Revista Contable, N 5.
Paper not yet in RePEc: Add citation now
- SHARPE, W. (1970): “Porfolio Theory and Capital Marketâ€. McGraw Hill, USA.
Paper not yet in RePEc: Add citation now
- SHILLER, R. (2001): Irrational exuberance, Broadway Books, USA.
Paper not yet in RePEc: Add citation now
TOBIN, J. (1969): “A general equilibrium approach to monetary theory, Q- de Tobinâ€. Journal of Money, Credit & Banking, Vol. 1, pp.15–29.
- TUTTICCI, I., KRISHMAN, G. y PERCY, M. (2007): “The role of external monitoring in firm valuation: The case of R&D capitalizationâ€. Journal of International Accounting Research, 62, pp. 83–107.
Paper not yet in RePEc: Add citation now
WHITE, H. (1980): “A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticityâ€. Econometrica, Vol. May, pp. 817–838.
ZÉGHAL, D. y MAALOUL, A. (2011): “The accounting treatment of intangibles–A critical review of the literatureâ€. Accounting Forum Vol. 35, No. 4, pp. 262–274.